These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23545806)

  • 1. In vitro metabolism and pharmacokinetic studies on methylone.
    Pedersen AJ; Petersen TH; Linnet K
    Drug Metab Dispos; 2013 Jun; 41(6):1247-55. PubMed ID: 23545806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrated pharmacokinetic and pharmacodynamic study of a new drug of abuse, methylone, a synthetic cathinone sold as "bath salts".
    López-Arnau R; Martínez-Clemente J; Carbó Ml; Pubill D; Escubedo E; Camarasa J
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():64-72. PubMed ID: 23603357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic Profiles and Pharmacodynamic Effects for Methylone and Its Metabolites in Rats.
    Elmore JS; Dillon-Carter O; Partilla JS; Ellefsen KN; Concheiro M; Suzuki M; Rice KC; Huestis MA; Baumann MH
    Neuropsychopharmacology; 2017 Feb; 42(3):649-660. PubMed ID: 27658484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sodium ozagrel on the activity of rat CYP2D6.
    Wu H; Yu W; Huang L; Wang J; Tang X; Yang W; Liu Y; Yu H; Zhu D
    Eur J Pharmacol; 2007 Nov; 573(1-3):55-9. PubMed ID: 17651725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro metabolism studies on mephedrone and analysis of forensic cases.
    Pedersen AJ; Reitzel LA; Johansen SS; Linnet K
    Drug Test Anal; 2013 Jun; 5(6):430-8. PubMed ID: 22573603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of human cytochrome P450 2D6 as major enzyme involved in the O-demethylation of the designer drug p-methoxymethamphetamine.
    Staack RF; Theobald DS; Paul LD; Springer D; Kraemer T; Maurer HH
    Drug Metab Dispos; 2004 Apr; 32(4):379-81. PubMed ID: 15039289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism-based inactivation of CYP2D6 by methylenedioxymethamphetamine.
    Heydari A; Yeo KR; Lennard MS; Ellis SW; Tucker GT; Rostami-Hodjegan A
    Drug Metab Dispos; 2004 Nov; 32(11):1213-7. PubMed ID: 15328252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of 3-[2-(N,N-diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin (AMMC) as a specific CYP2D6 probe in human liver microsomes.
    Chauret N; Dobbs B; Lackman RL; Bateman K; Nicoll-Griffith DA; Stresser DM; Ackermann JM; Turner SD; Miller VP; Crespi CL
    Drug Metab Dispos; 2001 Sep; 29(9):1196-200. PubMed ID: 11502727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of experimental design on assessing mechanism-based inactivation of CYP2D6 by MDMA (Ecstasy).
    Van LM; Heydari A; Yang J; Hargreaves J; Rowland-Yeo K; Lennard MS; Tucker GT; Rostami-Hodjegan A
    J Psychopharmacol; 2006 Nov; 20(6):834-41. PubMed ID: 16478752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of the time-dependent inactivation of CYP2D6 in cryopreserved human hepatocytes by methylenedioxymethamphetamine (MDMA).
    Van LM; Swales J; Hammond C; Wilson C; Hargreaves JA; Rostami-Hodjegan A
    Eur J Pharm Sci; 2007 May; 31(1):53-61. PubMed ID: 17387004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on Para-Methoxymethamphetamine (PMMA) Metabolite Pattern and Influence of CYP2D6 Genetics in Human Liver Microsomes and Authentic Samples from Fatal PMMA Intoxications.
    Vevelstad M; Øiestad EL; Nerem E; Arnestad M; Bogen IL
    Drug Metab Dispos; 2017 Dec; 45(12):1326-1335. PubMed ID: 28978661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vitro mechanistic study to elucidate the desipramine/bupropion clinical drug-drug interaction.
    Reese MJ; Wurm RM; Muir KT; Generaux GT; St John-Williams L; McConn DJ
    Drug Metab Dispos; 2008 Jul; 36(7):1198-201. PubMed ID: 18420781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidation of methamphetamine and methylenedioxymethamphetamine by CYP2D6.
    Lin LY; Di Stefano EW; Schmitz DA; Hsu L; Ellis SW; Lennard MS; Tucker GT; Cho AK
    Drug Metab Dispos; 1997 Sep; 25(9):1059-64. PubMed ID: 9311621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the human liver cytochrome P450 isoenzyme responsible for the 6-methylhydroxylation of the novel anticancer drug 5,6-dimethylxanthenone-4-acetic acid.
    Zhou S; Paxton JW; Tingle MD; Kestell P
    Drug Metab Dispos; 2000 Dec; 28(12):1449-56. PubMed ID: 11095582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular docking and enzyme kinetic studies of dihydrotanshinone on metabolism of a model CYP2D6 probe substrate in human liver microsomes.
    Zhou X; Wang Y; Or PM; Wan DC; Kwan YW; Yeung JH
    Phytomedicine; 2012 May; 19(7):648-57. PubMed ID: 22541637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists.
    Martínez C; Albet C; Agúndez JA; Herrero E; Carrillo JA; Márquez M; Benítez J; Ortiz JA
    Clin Pharmacol Ther; 1999 Apr; 65(4):369-76. PubMed ID: 10223772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism-based inactivation of CYP2D6 by 5-fluoro-2-[4-[(2-phenyl-1H-imidazol-5-yl)methyl]-1-piperazinyl]pyrimidine.
    Palamanda JR; Casciano CN; Norton LA; Clement RP; Favreau LV; Lin C; Nomeir AA
    Drug Metab Dispos; 2001 Jun; 29(6):863-7. PubMed ID: 11353755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyp2D6 catalyzes 5-hydroxylation of 1-(2-pyrimidinyl)-piperazine, an active metabolite of several psychoactive drugs, in human liver microsomes.
    Raghavan N; Zhang D; Zhu M; Zeng J; Christopher L
    Drug Metab Dispos; 2005 Feb; 33(2):203-8. PubMed ID: 15507542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylone and mCPP, two new drugs of abuse?
    Bossong MG; Van Dijk JP; Niesink RJ
    Addict Biol; 2005 Dec; 10(4):321-3. PubMed ID: 16318952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of cytochrome p450 enzymes involved in the metabolism of 4'-methyl-alpha-pyrrolidinopropiophenone, a novel scheduled designer drug, in human liver microsomes.
    Springer D; Paul LD; Staack RF; Kraemer T; Maurer HH
    Drug Metab Dispos; 2003 Aug; 31(8):979-82. PubMed ID: 12867484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.